Blog - Page 1125 of 5707

FridayDec 10, 2021 11:31 am

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces Replays Available from Sequire Clean Tech Conference

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS (“SaaS”) platform, has made available key presentations from its Sequire Clean Tech & Electric Vehicles Conference. The premier virtual investor event was held on Dec. 6, 2021, and featured presentations from more than 25 elite stock market companies that are leading the way in the clean-tech space; the event also included insightful addresses and discussions with industry execs looking at the future of clean tech. Topics covered electric vehicles, energy and power, and materials and chemicals. Replays of the keynote…

FridayDec 10, 2021 11:10 am

QualityStocksNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Announces Publication of Technical Paper on Biophysics-Based CDA Cancer Detection Technology

AnPac Bio (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, today announced that its joint technical paper on novel Cancer Differentiation Analysis (“CDA”) Technology for multi-cancer screening with multiple leading medical institutions was accepted and published online. The piece was published on Nov. 30 by the Expert Review of Molecular Diagnostics, a peer-reviewed international medical journal that has an impact factor of 5.2. “We are very pleased with the publication of our technical paper on CDA cancer detection technology by a peer-reviewed international journal in the field of medicine,” said Dr. Chris Yu, AnPac Bio’s…

FridayDec 10, 2021 10:30 am

QualityStocksNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Announces Upcoming Investor Call

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) CEO and other key leaders will be hosting a year-end update call. The call, which will be held on Dec. 15, 2021, at 1 p.m. ET, will also include a discussion about the company’s growth strategy looking forward. According to the company, the one-hour call will include opening remarks, and overview presentation and update, and a Q&A session. Avricore Health is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward. “We’ve had our best year yet, despite many external factors that created headwinds, and we’re extremely excited to head…

FridayDec 10, 2021 10:20 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Upcoming R&D Programs Targeting Global Markets Totaling Over $160 Billion

Lexaria Bioscience plans to launch approximately 12 applied research and development programs in 2022 The programs are designed to explore the ability of the company’s patented DehydraTECH(TM) to improve drug delivery processes for multiple indications Research will continue into the use of DehydraTECH-CBD for high blood pressure, as well as the technology’s potential for oral nicotine delivery Diabetes, rheumatoid disease, Alzheimer’s Disease, and estrogen delivery, are some of the multiple indications that drug delivery platform innovator Lexaria Bioscience (NASDAQ: LEXX) is planning to target with its research and development programs next year. The markets targeted provide multiple opportunities for success…

FridayDec 10, 2021 9:42 am

SPYR Inc. (SPYR) Is ‘One to Watch’

Applied Magix is currently shipping five products to customers The company plans to add new products to its offerings in 2022 Applied Magix is positioned to take advantage of unmet demand for Apple-compatible smart home and connected car products The global smart home market is forecast to hit more than $187 billion in revenue by 2025, marking a CAGR of 15.75 percent from 2021 The company operates in rapidly growing markets Both SPYR and its Applied MagiX subsidiary have experienced management teams in place SPYR (OTCQB: SPYR), dba SPYR Technologies, is a technology company which, through its Applied MagiX Inc.…

FridayDec 10, 2021 9:31 am

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) New Patent Application Offering Improved Delivery Control, Enhanced Shelf Stability, of Psilocin

The full patent application covers multiple families of psilocin analogs. Psilocin is the active metabolite of psilocybin In addition to improving delivery control, the company’s dermal application route can potentially eliminate undesirable side effects such as nausea Mydecine appoints Dr. Saeid Babaei, PhD, as an independent board member. The appointment can help advance the company’s NASDAQ listing efforts, bringing decades of experience in biotech development and licensing and strategic advancements Company intends to uplist to NASDAQ in Q1 2022 Improving delivery control and shelf stabilization of psilocybin’s active metabolite psilocin, two critical aspects for use in medical settings, is the…

ThursdayDec 09, 2021 2:43 pm

QualityStocksNewsBreaks – Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Announces Financing to Provide Runway for Key Milestones

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA), a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders, today announced its entry into an agreement with an investor to complete a non-brokered private placement (the “financing”) of a convertible secured subordinated debenture in the principal amount of C$5.5 million. According to the update, the financing is expected to close on Dec. 10, 2021. “I would like to thank our incredible strategic shareholder for stepping up in a tough, volatile market and continuing to support and expand upon your large stake in Mydecine,” said the…

ThursdayDec 09, 2021 2:27 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) Study Marks First Phase 2 Trial to Evaluate Cannabinol as Therapeutic Option for Disease Treatment

InMed Pharmaceuticals (NASDAQ: INM) recently released its Q1 2022 financial results along with a business update showing positive momentum across all of its programs. Following the acquisition of BayMedica Inc. in October that created an industry leader in the manufacture and commercialization of rare cannabinoids, management expects to introduce multiple new, rare cannabinoids in the near future, focusing on high demand, attractive margin products. In late September, InMed commenced the 755-201-EB study, its phase 2 clinical trial of INM-755 (cannabinol) cream for the treatment of a group of rare skin disorders scientifically known as Epidermolysis Bullosa (“EB”). A recent article…

ThursdayDec 09, 2021 2:15 pm

FingerMotion Inc. (FNGR) Research Agreement with Munich Re Sets Stage for Predictive Insurance Analysis Growth

Rich communication services (“RCS”) provider and big data analysis solutions developer FingerMotion has announced an agreement with Munich Re to form a collaborative research alliance to benefit life and health insurance risk evaluation FingerMotion focuses its SMS, MMS, and big data products on China’s huge high-end phone consumer market The company’s most recent quarterly report noted a 25 percent YOY quarterly growth in revenues attributed to SMS and MMS services The Munich Re agreement follows FingerMotion’s contract earlier this year with Pacific Life Reinsurance to provide big data analytical services for Pacific Life’s insurance operations in China Communications and big…

ThursdayDec 09, 2021 1:59 pm

QualityStocksNewsBreaks – DigiMax Global Inc.’s (CSE: DIGI) (OTC: DBKSF) AI Solution Helping Employers Identify Right Talent, Users Identify Personality Traits

DigiMax Global (CSE: DIGI) (OTC: DBKSF), a company that provides artificial intelligence (“AI”) and cryptocurrency technology solutions, is poised to benefit from the fact that AI technology may just be what companies need to make decisions on hiring the right talent and personality for a job. DIGI’s Projected Personality Interpreter (“PPI”), which was originally conceived and launched by Darwin Ecosystems, a company that was acquired by DigiMax late last year, evaluates a company’s workforce, brand and culture by revealing the personality traits and sentiments buried in human expression. “By leveraging IBM Watson and a customer algorithm that analyzes applicant responses across…

Site Search

Company Search